125 related articles for article (PubMed ID: 9815553)
1. MYCN protein expression as a predictor of neuroblastoma prognosis.
Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
[TBL] [Abstract][Full Text] [Related]
2. MYCN gene amplification. Identification of cell populations containing double minutes and homogeneously staining regions in neuroblastoma tumors.
Yoshimoto M; Caminada De Toledo SR; Monteiro Caran EM; de Seixas MT; de Martino Lee ML; de Campos Vieira Abib S; Vianna SM; Schettini ST; Anderson Duffles Andrade J
Am J Pathol; 1999 Nov; 155(5):1439-43. PubMed ID: 10550298
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the relationship between MYCN gene and serum NSE and urinary VMA levels and neuroblastoma pathological features and prognosis.
Zhang H; He X; Miao Q; Li L; Song J; Jiang X
Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):134-139. PubMed ID: 38678619
[TBL] [Abstract][Full Text] [Related]
4. Posttreatment complications in pediatric cervical neuroblastoma: A retrospective case series at a tertiary cancer center.
Lopez J; Subramanian T; Durell J; Levyn H; Wong R; Shah J; LaQuaglia MP; Gerstle JT
J Surg Oncol; 2024 Feb; 129(2):219-223. PubMed ID: 37850570
[TBL] [Abstract][Full Text] [Related]
5. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Campbell K; Kao PC; Naranjo A; Kamijo T; Ramanujachar R; London WB; DuBois SG
Pediatr Blood Cancer; 2023 Feb; 70(2):e30054. PubMed ID: 36316811
[TBL] [Abstract][Full Text] [Related]
6. Exportin-T: A Novel Prognostic Predictor and Potential Therapeutic Target for Neuroblastoma.
Pan LJ; Chen JL; Wu ZX; Wu YM
Technol Cancer Res Treat; 2021; 20():15330338211039132. PubMed ID: 34469238
[TBL] [Abstract][Full Text] [Related]
7. Stage 4N neuroblastoma before and during the era of anti-G
Kushner BH; LaQuaglia MP; Cardenas FI; Basu EM; Gerstle JT; Kramer K; Roberts SS; Wolden SL; Cheung NV; Modak S
Int J Cancer; 2023 Dec; 153(12):2019-2031. PubMed ID: 37602920
[TBL] [Abstract][Full Text] [Related]
8. Prediction of MYCN Gene Amplification in Pediatric Neuroblastomas: Development of a Deep Learning-Based Tool for Automatic Tumor Segmentation and Comparative Analysis of Computed Tomography-Based Radiomics Features Harmonization.
Yeow LY; Teh YX; Lu X; Srinivasa AC; Tan E; Tan TSE; Tang PH; Kn BP
J Comput Assist Tomogr; 2023 Sep-Oct 01; 47(5):786-795. PubMed ID: 37707410
[TBL] [Abstract][Full Text] [Related]
9. Infantile mediastinal neuroblastoma presenting as an oncologic emergency: usefulness of serum-based
Suematsu M; Yagyu S; Hosoi H; Iehara T
BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972781
[TBL] [Abstract][Full Text] [Related]
10. Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study.
Vermeulen J; De Preter K; Naranjo A; Vercruysse L; Van Roy N; Hellemans J; Swerts K; Bravo S; Scaruffi P; Tonini GP; De Bernardi B; Noguera R; Piqueras M; Cañete A; Castel V; Janoueix-Lerosey I; Delattre O; Schleiermacher G; Michon J; Combaret V; Fischer M; Oberthuer A; Ambros PF; Beiske K; Bénard J; Marques B; Rubie H; Kohler J; Pötschger U; Ladenstein R; Hogarty MD; McGrady P; London WB; Laureys G; Speleman F; Vandesompele J
Lancet Oncol; 2009 Jul; 10(7):663-71. PubMed ID: 19515614
[TBL] [Abstract][Full Text] [Related]
11.
Olivera GG; Yáñez Y; Gargallo P; Sendra L; Aliño SF; Segura V; Sanz MÁ; Cañete A; Castel V; Font De Mora J; Hervás D; Berlanga P; Herrero MJ
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295184
[TBL] [Abstract][Full Text] [Related]
12. Correlations between contrast-enhanced CT-measured extracellular volume fraction, histopathological features, and MYCN amplification status in abdominal neuroblastoma: a retrospective study.
Wang H; Ding H; Xie M; Zhang L; Li T; Qin J; Chen X; He L
Abdom Radiol (NY); 2023 Nov; 48(11):3441-3448. PubMed ID: 37452211
[TBL] [Abstract][Full Text] [Related]
13. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma.
Ruiz-Pérez MV; Sainero-Alcolado L; Oliynyk G; Matuschek I; Balboni N; Ubhayasekera SJKA; Snaebjornsson MT; Makowski K; Aaltonen K; Bexell D; Serra D; Nilsson R; Bergquist J; Schulze A; Arsenian-Henriksson M
iScience; 2021 Feb; 24(2):102128. PubMed ID: 33659885
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of MYCN-activating mutation and amplification in a patient with neuroblastoma.
Kojima M; Touge R; Kurihara S; Saeki I; Takahashi S; Hiyama E
Pediatr Blood Cancer; 2024 May; ():e31115. PubMed ID: 38773728
[No Abstract] [Full Text] [Related]
16. Chelators as Antineuroblastomas Agents.
D'Acunto CW; Gbelcová H; Kaplánek R; Pospíšilová M; Havlík M; Ruml T
Physiol Res; 2023 Oct; 72(S3):S277-S286. PubMed ID: 37888971
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase USP28 maintains the expression of the transcription factor MYCN and is essential in neuroblastoma cells.
Li J; Peng J; Wu L; Shen X; Zhen X; Zhang Y; Ma H; Xu Y; Xiong Q; Zhu Q; Zhang P
J Biol Chem; 2023 Jul; 299(7):104856. PubMed ID: 37230388
[TBL] [Abstract][Full Text] [Related]
18. MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment.
Bartolucci D; Montemurro L; Raieli S; Lampis S; Pession A; Hrelia P; Tonelli R
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139583
[TBL] [Abstract][Full Text] [Related]
19. MYCN protein stability is a better prognostic indicator in neuroblastoma.
Yang Y; Zhao J; Zhang Y; Feng T; Yv B; Wang J; Gao Y; Yin M; Tang J; Li Y
BMC Pediatr; 2022 Jul; 22(1):404. PubMed ID: 35820898
[TBL] [Abstract][Full Text] [Related]
20. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.
Wang H; Wang X; Xu L; Zhang J
BMC Pediatr; 2022 Jun; 22(1):376. PubMed ID: 35764946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]